Among the 45 patients requiring insulin when a GLP1RA therapy was added on, 20 (33.2%) and 31 (45.5%) could suspend insulin therapy at, respectively, 6 and 18 months
The inclusion of saliva-based test strips enables monitoring and optimizing vitamin C intake based on individual needs
Incretin-based antidiabetic therapies, such as glucagon-like peptide-1 receptor agonists (GLP-1RAs), may offer benefits for individuals at risk of neurodegeneration due to their central effects on appetite and satiety regulation via the hypothalamus (Reich and Holscher, 2022)
Sin embargo, el nico uso del frmaco no provocar la prdida de peso, sino que es ms bien un potenciador de cambio hacia unos hbitos alimenticios ms saludables
Small molecule drug discovery at the glucagon-like peptide-1 receptor
Iron and intracerebral hemorrhage: from mechanism to translation